WillItSurvive

Makes starches, sweeteners, and food ingredients from corn and other crops for global food makers.

Defensible for now
Assessed 25 July 2026 · Evidence as of 25 July 2026
Real protection, with named pressure against it.
On the recordSince 25 July 2026 · Checkable from August 4, 2026 · Every call on the record Checkpoint: Q2 2026 earnings report, first full read after Q1's revenue miss and the Tate & Lyle deal announcement
The call

Ingredion is a stable ingredient supplier with shrinking core revenue, now betting a $5 billion acquisition of Tate & Lyle will offset that decline once it closes in 2027.

Ingredion buys corn and other crops, then sells refined starches and sweeteners to food makers and restaurants. It is hard to replace because food companies get locked into using its products through long-term contracts, custom product development, and regulatory approval; Cargill and ADM are larger and compete, but Ingredion holds its own. The big question is whether Ingredion can successfully buy and merge with Tate & Lyle starting in late 2027 without stumbling on integration, layoffs, or regulatory hold-ups, since flat revenue and a $5 billion deal make the next few years risky.

Why
01
AI pressure: None apparent. AI shows up as a tool here, like the Shiru partnership and an Ask Ingredion assistant, not as a rival eating their business. Could AI do the core job? Unlikely.
02
Bigger players: Cargill and ADM. Both are bigger grain traders with more scale in the same starches and fibers markets, competing head to head with Ingredion today. Could a giant copy it? Probably.
03
What protects it. Long-term contracts, regulatory approvals baked into customer formulas, and physical plants that are costly to replace or switch away from.
What would change this call
Tate & Lyle shareholder vote and antitrust clearance outcome by H2 2027. Blocked or delayed deal would show execution risk and weaker growth path.
Q2 2026 earnings release on August 4, 2026 revenue and EPS versus consensus. A third straight revenue decline would confirm core business weakening.
Reported progress toward the $130M cost-synergy target after deal close. Missed synergy milestones would signal integration trouble and margin pressure.
Key numbers
  • FY2025 net sales $7.2B, down 2.8% year over year (2026-02-02)
  • Q1 2026 revenue $1.79B, down 1.2%, EPS missed estimates (2026-07-20)
  • Tate & Lyle acquisition priced near $5.0B, closing expected H2 2027 (2026-06-08)
Named risks
  • Tate & Lyle deal could be delayed or blocked by regulatory or shareholder approval before H2 2027 close. Severity: high
  • Core revenue declined in FY2025 (-2.8%) and Q1 2026 (-1.2%), with an EPS miss versus consensus. Severity: medium
  • Post-merger integration must hit $130M synergy target by 2030, risking role duplication and restructuring. Severity: medium
  • Cargill and ADM retain larger procurement and grain-trading scale advantages over Ingredion. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
CargillcontestingLarger grain-trading scale; Ingredion pursuing Tate & Lyle deal (announced 2026-06-08) to close gap
ADMcontestingBigger diversified procurement scale; no visible share loss confirmed as of mid-2026
Tate & Lylegaining onIngredion agreed to acquire Tate & Lyle for ~$5.0bn, announced 2026-06-08, closing H2 2027
Roquette FrerescontestingListed among five-player starch/specialty ingredient oligopoly per 2025-05-06 industry report
Agrana Beteiligungs-AGcontestingNamed peer competitor in industrial starch market report, 2025-05-06
Questions people ask
Is Ingredion profitable in 2026?
Yes. Ingredion reported FY2025 EPS of $11.18 (up from $9.71 in FY2024) despite net sales falling ~2.8% to $7.2 billion, per its February 2, 2026 earnings release. Q1 2026 revenue was $1.79 billion, down 1.2% YoY, with an adjusted EPS miss of $2.34.
Is Ingredion being acquired?
No, Ingredion is the acquirer. On June 8, 2026 it announced a recommended all-cash acquisition of Tate & Lyle PLC for roughly £3.7bn (~$5.0bn), 595 pence per share, a 59% premium, expected to close H2 2027.
Who is Ingredion's biggest competitor?
Cargill and ADM, both larger diversified grain-trading firms with greater procurement scale, are Ingredion's chief rivals alongside Tate & Lyle, Roquette Frères, and Agrana. Ingredion is acquiring Tate & Lyle (announced June 8, 2026, ~$5.0bn) partly to close that scale gap.
Could AI replace Ingredion's ingredient business?
Unlikely. Ingredion frames AI as additive: it launched the 'Ask Ingredion' formulation assistant (announced July 2026) and partnered with AI-protein startup Shiru and biotech Holobiome (March 2026), while its regulatory qualifications and physical manufacturing remain AI-resistant moats.
Is Ingredion laying off employees?
No major layoffs are confirmed. Ingredion's own July 14, 2026 release cites 'more than 11,000 employees,' and Macrotrends shows roughly 11,200 in both FY2024 and FY2025, indicating a broadly flat headcount trend, not active reductions.
Is Ingredion stock volatile right now?
Yes. Ingredion's 52-week range spans $94.44 to $134.77 as of July 24, 2026, with market cap near $6.3 billion. Q1 2026 adjusted EPS of $2.34 missed the $2.44-$2.50 consensus, adding to volatility around the pending Tate & Lyle deal.
Timeline
  • 2026-07-14Ingredion schedules Q2 2026 earnings release for August 4, 2026
  • 2026-07-07Launches 'Ask Ingredion' conversational AI formulation assistant
  • 2026-06-08Announces recommended all-cash acquisition of Tate & Lyle for ~$5.0 billion
  • 2026-04-01Former Glanbia CEO Siobhán Talbot joins Ingredion board
  • 2026-03-23Director Gregory Kenny retires from Ingredion board
  • 2026-03-17Partners with AI protein-discovery startup Shiru and biotech Holobiome
  • 2026-02-02Reports FY2025 net sales of $7.2 billion, down 2.8% YoY, EPS $11.18
  • 2025-09-17Investor day discloses predictive AI tools for formulation innovation
  • 2024-02Launches NOVATION Indulge 2940 non-GMO native corn starch
  • 2012Company renamed Ingredion from Corn Products International
Revision history
25 July 2026
First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources